KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Receivables (2016 - 2025)

Historic Receivables for Cme (CME) over the last 17 years, with Q3 2025 value amounting to $642.9 million.

  • Cme's Receivables rose 214.49% to $642.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $642.9 million, marking a year-over-year increase of 214.49%. This contributed to the annual value of $573.1 million for FY2024, which is 700.15% up from last year.
  • Cme's Receivables amounted to $642.9 million in Q3 2025, which was up 214.49% from $667.6 million recorded in Q2 2025.
  • Over the past 5 years, Cme's Receivables peaked at $770.2 million during Q1 2025, and registered a low of $434.5 million during Q4 2021.
  • Over the past 5 years, Cme's median Receivables value was $582.3 million (recorded in 2022), while the average stood at $586.5 million.
  • Its Receivables has fluctuated over the past 5 years, first plummeted by 3159.93% in 2021, then surged by 2334.18% in 2022.
  • Over the past 5 years, Cme's Receivables (Quarter) stood at $434.5 million in 2021, then grew by 11.21% to $483.2 million in 2022, then increased by 10.84% to $535.6 million in 2023, then rose by 7.0% to $573.1 million in 2024, then grew by 12.18% to $642.9 million in 2025.
  • Its last three reported values are $642.9 million in Q3 2025, $667.6 million for Q2 2025, and $770.2 million during Q1 2025.